SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-020161
Filing Date
2024-02-26
Accepted
2024-02-26 16:11:28
Documents
135
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fgen-20231231.htm   iXBRL 10-K 5330633
2 EX-10.5 fgen-ex10_5.htm EX-10.5 79972
3 EX-10.53 fgen-ex10_53.htm EX-10.53 26272
4 EX-23.1 fgen-ex23_1.htm EX-23.1 2423
5 EX-31.1 fgen-ex31_1.htm EX-31.1 11055
6 EX-31.2 fgen-ex31_2.htm EX-31.2 11253
7 EX-32.1 fgen-ex32_1.htm EX-32.1 7243
8 EX-97.1 fgen-ex97_1.htm EX-97.1 51685
9 GRAPHIC img64793345_0.jpg GRAPHIC 183490
  Complete submission text file 0000950170-24-020161.txt   22686915

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20231231.xsd EX-101.SCH 3006388
137 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20231231_htm.xml XML 4574667
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36740 | Film No.: 24678824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)